Results 211 to 220 of about 1,871,454 (260)

Diabetes Increases Immunotherapy‐Related Toxicity but Not Efficacy in Metastatic Non‐Small Cell Lung Cancer: A Multicenter Retrospective Study

International Journal of Cancer, EarlyView.
ABSTRACT This multicenter retrospective study evaluated the impact of type 2 diabetes mellitus (DM) on clinical outcomes and immune‐related adverse events (irAEs) in 450 patients with metastatic non‐small cell lung cancer (NSCLC) treated with second‐line nivolumab at 17 centers between 2016 and 2024. Among these patients, 118 (26.2%) had DM.
Emre Çakır, Didem Divriklioğlu, Deniz Can Güven, Gamze Serin Özel, Oğuzhan Yıldız, Gamze Emin, Merve Keskinkılıç, Yeşim Ağyol, Onur Yazdan Balçık, Nagihan Kolkıran, Hale Gülçin Yıldırım Doğan, Pervin Can Şancı, Özge Yalıcı, Teoman Şakalar, Yurdagül Danacı, Yakup Düzköprü, Canan Yıldız, Mesut Yılmaz, İlhan Hacıbekiroğlu, Bülent Erdoğan, Saadettin Kılıçkap, Gamze Gököz Doğu, Melek Karakurt Eryılmaz, Atila Yıldırım, İlhan Öztop, İbrahim Vedat Bayoğlu, Şahnura Uzuntaş, Atike Pınar Erdoğan, Emir Çelik, Devrim Çabuk, Erdoğan Selçuk Şeber, Zehra Sadak Öcal, Hacer Demir   +32 more
wiley   +1 more source

Risk of Developing Subsequent Primary Colorectal Cancers Among Non‐Colorectal Cancer Survivors: Implications for Prevention and Screening

International Journal of Cancer, EarlyView.
ABSTRACT Cancer survivors have an elevated risk of developing subsequent primary cancers, including colorectal cancer (CRC), and may benefit from tailored screening approaches to reduce incidence and morbidity. A retrospective cohort of adults diagnosed with cancer (excluding CRC) in Alberta, Canada from 2000 to 2021 who survived at least 6 months was ...
Dylan E. O'Sullivan, Robert J. Hilsden, Hannah Harsanyi, Matthew T. Warkentin, Kareem Jamani, Huiming Yang, Darren R. Brenner, Safiya Karim, Winson Y. Cheung, Yibing Ruan   +9 more
wiley   +1 more source

Brain metastases as a manifestation of late relapse in high-grade serous ovarian cancer: Diagnostic and therapeutic challenges. [PDF]

Radiol Case Rep
Berrada N, Bigi S, Mokfi R, Bennour S, Senoussi C, Bouhou I, Nadif L, Lamine L, Lazrak M, Boutaggount F, Maskrout M, Wakrim S, Rais G.   +12 more
europepmc   +1 more source

Association Between Temporal Muscle Thickness and Survival in Older Patients With Brain Metastases Undergoing Radiation Therapy. [PDF]

Cancer Rep (Hoboken)
Pikkarainen L, Korhonen TK, Tolonen A, Pesonen EK, Hernandez N, Skyttä T, Arponen O.   +6 more
europepmc   +1 more source

Outcomes of hypofractionated stereotactic radiotherapy for brain metastases: do we treat patients or lesions? [PDF]

BMC Cancer
Figen M, Kirli Bolukbas M, Soydemir GP, Kocak Uzel E.   +3 more
europepmc   +1 more source

Discordance between clinician- and patient-reported outcomes during radiotherapy for brain metastases: the prospective NeuroPRO study. [PDF]

Clin Transl Radiat Oncol
Dejonckheere CS, Layer YL, Potthoff AL, Zeyen T, Caglayan L, Grau F, Wiegreffe S, Glasmacher AR, Kersting L, Kossmann MRP, Zeller M, Nour Y, Layer K, Leitzen C, Scafa D, Radbruch A, Vatter H, Marx AM, Herrlinger U, Schneider M, Sarria GR, Gkika E, Layer JP.   +22 more
europepmc   +1 more source